# Benchmarking AlphaVariant on `eqFP611_joint` for Multi-Objective Fluorescence Optimization

**Author:** Manus AI  
**Date:** May 31, 2026  
**Task:** Evaluate AlphaVariant on a two-objective protein engineering problem in which the goal is to maximize **blue fluorescence** and **red fluorescence** simultaneously.

## Executive Summary

The `eqFP611_joint` benchmark should be framed as a **true multi-objective optimization** problem rather than as a single-property optimization problem. The available metrics indicate that blue and red fluorescence exhibit an inherent trade-off, with a reported correlation of **r = −0.279**, meaning that methods should be rewarded not only for finding high-red or high-blue variants, but for efficiently discovering variants that expand the **upper-right Pareto frontier** of the blue–red objective space.[1]

The clearest benchmarking design is to evaluate AlphaVariant at two levels. First, assess **search performance** using multi-objective metrics such as **hypervolume**, **Pareto coverage fraction**, and **distance to the ideal point**. Second, assess **candidate utility** using scalarized selection metrics such as **geometric mean/product score**, **max-min score**, and **dual-threshold hit rate**. This separation avoids conflating two different scientific questions: whether AlphaVariant maps the trade-off frontier well, and whether it returns practically useful dual-fluorescent variants.

| Evaluation Question | Recommended Primary Metric | Secondary Metrics | Interpretation |
|---|---:|---:|---|
| Does AlphaVariant efficiently discover the blue–red trade-off frontier? | **Hypervolume** | Pareto coverage, non-dominated count | Higher values indicate better multi-objective search behavior. |
| Does AlphaVariant recover the known globally Pareto-optimal sequences? | **Pareto coverage fraction** | Time-to-Pareto discovery | Measures whether AlphaVariant finds the true global trade-off solutions. |
| Does AlphaVariant produce balanced dual-fluorescent hits? | **Geometric mean/product score** | Max-min score, dual-threshold hit rate | Rewards variants with simultaneously strong blue and red fluorescence. |
| Does AlphaVariant find the best practical compromise? | **Distance to ideal point** | Rank of nearest compromise variant | Identifies the discovered variant closest to the unachievable blue/red maximum. |

## 1. Benchmark Objective

The benchmark objective is to test whether AlphaVariant can efficiently optimize protein variants when **two experimentally measured objectives must be maximized jointly**. In this case, the two objectives are blue fluorescence and red fluorescence. Because the objectives are negatively correlated, the benchmark should explicitly test AlphaVariant’s ability to navigate trade-offs rather than expecting one sequence to dominate both objectives globally.

> **Benchmark goal:** Given a fixed experimental or in silico query budget, AlphaVariant should identify sequence variants that maximize blue fluorescence and red fluorescence jointly, recover as much of the true Pareto frontier as possible, and return balanced dual-fluorescent candidates suitable for downstream validation.

This framing makes the task appropriate for comparing AlphaVariant against standard protein design and black-box optimization baselines. It also makes the results easy to interpret biologically, because the final output is not only a performance curve but also a ranked list of promising variants.

## 2. Dataset Setup and Preprocessing

The `eqFP611_joint` dataset should be treated as a fully enumerated or partially enumerated landscape, depending on its actual availability in your pipeline. The benchmark should use the full dataset only for **offline evaluation**, while the optimization algorithm should observe labels only for variants it is allowed to query during each run.

Before running any method, blue and red fluorescence values should be normalized using a consistent transformation. The most interpretable default is min–max normalization using the full dataset range for each objective when the benchmark is purely retrospective. If you want to simulate a more realistic prospective setting, compute normalization statistics from the training/initialization pool and report this choice explicitly.

| Step | Recommendation | Rationale |
|---|---|---|
| Objective direction | Maximize both blue and red fluorescence | Ensures all metrics are aligned toward the upper-right objective region. |
| Normalization | Use min–max normalization separately for blue and red | Makes scalarized metrics comparable across channels. |
| Reference point for hypervolume | Use the dataset-wise minimum blue and red values, or a slightly worse point | Ensures dominated area is measured consistently across methods. |
| Ideal point | Use `(Blue_max, Red_max)` from the full dataset | Defines the theoretical utopia point for compromise analysis. |
| True Pareto set | Use the reported 10 globally Pareto-optimal sequences | Enables direct Pareto recovery measurement.[1] |

The normalized objectives can be denoted as:

\[
\tilde{B}(x)=\frac{B(x)-B_{min}}{B_{max}-B_{min}}, \quad
\tilde{R}(x)=\frac{R(x)-R_{min}}{R_{max}-R_{min}}
\]

where \(B(x)\) and \(R(x)\) are the measured blue and red fluorescence values for sequence \(x\). These normalized values should be used for product score, max-min score, distance to the ideal point, and optionally hypervolume if you want the reported HV values to be scale-free.

## 3. Experimental Protocol

AlphaVariant should be evaluated under a fixed-budget sequential optimization protocol. Each run begins with an initial set of labeled variants, after which AlphaVariant proposes batches of new variants. The benchmark then reveals the blue and red fluorescence labels for those proposed variants from the dataset and updates the observed set.

To reduce sensitivity to initialization, the benchmark should use multiple random seeds and report confidence intervals. A practical default is **20 independent runs** per method, although this can be reduced if compute is limited. Query budgets should be selected to reflect realistic experimental constraints and should include several checkpoints, such as 50, 100, 200, and 500 queried variants, if the dataset size permits.

| Component | Suggested Setting | Notes |
|---|---:|---|
| Initial labeled set | 24–96 variants | Use random, diversity-based, or wild-type-centered initialization depending on AlphaVariant’s expected use case. |
| Batch size | 8–24 variants per round | Should match realistic experimental throughput. |
| Total budget | 100–500 variants | Report performance as a function of budget, not only at the final budget. |
| Replicates | 10–20 random seeds | Needed for reliable comparisons across stochastic methods. |
| Evaluation frequency | After every batch | Enables hypervolume and Pareto discovery curves. |
| Held-out oracle | Full `eqFP611_joint` labels | Used only to reveal labels for queried sequences and compute final metrics. |

The benchmark should avoid giving AlphaVariant access to the complete labeled landscape during optimization. If AlphaVariant uses a pretrained representation or prior information, that should be documented separately from the active optimization loop.

## 4. Primary Search Metrics

### 4.1 Hypervolume Indicator

**Hypervolume** should be the primary algorithmic metric because it measures the amount of blue–red objective space dominated by the discovered set. In this task, a higher hypervolume means that AlphaVariant is finding variants that push the discovered frontier toward better blue fluorescence, better red fluorescence, or better combinations of both.

Use the non-dominated subset of discovered variants at each budget checkpoint. The reference point should be fixed across all methods, preferably the dataset-wise minimum point or a point slightly below the minimum after normalization.

| Metric | Definition | Report As | Why It Matters |
|---|---|---|---|
| Hypervolume | Dominated area of discovered non-dominated set relative to fixed reference point | Mean ± standard error over seeds | Captures both quality and diversity of the discovered frontier. |
| Hypervolume regret | Full-dataset Pareto HV minus discovered HV | Lower is better | Shows how far the method remains from the known landscape optimum. |
| Area under HV curve | Integral of HV over query budget | Higher is better | Rewards methods that find good variants early, not only eventually. |

The main figure should plot **hypervolume versus number of queried variants**. This single curve will likely be the most persuasive evidence that AlphaVariant is efficient in the multi-objective setting.

### 4.2 Pareto Coverage Fraction

Because the user-provided metrics indicate that the landscape contains **10 true globally Pareto-optimal sequences**, the benchmark can report the fraction of those true Pareto sequences recovered by each method.[1] This is a particularly interpretable metric for readers because it maps directly onto global discovery.

\[
\text{Pareto Coverage}(S_t)=\frac{|S_t \cap P^*|}{|P^*|}
\]

where \(S_t\) is the set of variants discovered by budget \(t\), and \(P^*\) is the true global Pareto set.

| Reported Value | Interpretation |
|---:|---|
| 0/10 | No true global trade-off variants recovered. |
| 5/10 | Half of the known Pareto frontier recovered. |
| 10/10 | Complete recovery of the true global Pareto frontier. |

This metric should be reported at each budget checkpoint and at the final budget. If some methods find near-Pareto variants but not exact Pareto sequences, include an additional relaxed metric such as **epsilon-Pareto coverage**.

## 5. Candidate Selection Metrics

The final candidate list should be evaluated separately from the search process. This matters because a method may achieve high hypervolume by finding extreme blue-only and red-only variants, while the practical engineering goal may be to identify balanced dual-fluorescent proteins.

### 5.1 Geometric Mean / Product Score

The primary single-candidate selection metric should be the product of normalized blue and red fluorescence:

\[
\text{ProductScore}(x)=\tilde{B}(x)\times\tilde{R}(x)
\]

This score strongly penalizes variants that perform poorly on either objective. A variant with very high red fluorescence but nearly zero blue fluorescence will receive a low product score, making the metric well aligned with the goal of identifying dual-color variants.

### 5.2 Max-Min Score

The max-min score should be used as a complementary fairness-style metric:

\[
\text{MaxMinScore}(x)=\min(\tilde{B}(x),\tilde{R}(x))
\]

This metric directly rewards the weaker of the two fluorescence channels. It is useful when the biological goal is to avoid lopsided variants and prioritize balanced performance.

### 5.3 Dual-Threshold Hit Rate

Define a hit as a sequence that exceeds a threshold for both blue and red fluorescence:

\[
\text{Hit}(x)=\mathbb{1}[B(x)\geq T_B \;\text{and}\; R(x)\geq T_R]
\]

The most interpretable threshold is often the wild-type value for each channel, if available. If the wild-type is not the relevant baseline, use percentile-based thresholds such as the 75th percentile for blue and the 75th percentile for red.

| Candidate Metric | Best Use | Recommended Reporting |
|---|---|---|
| Product score | Ranking dual-fluorescent variants | Top-1, top-5, and top-10 discovered product scores. |
| Max-min score | Finding balanced variants | Best discovered max-min score and sequence rank. |
| Dual-threshold hit rate | Practical engineering success | Number and fraction of discovered variants passing both thresholds. |
| Distance to ideal point | Identifying best compromise | Minimum distance among discovered variants. |

## 6. Distance to the Ideal Point

The ideal point is defined as the coordinate containing the maximum blue fluorescence and maximum red fluorescence observed anywhere in the full dataset:

\[
U=(B_{max},R_{max})
\]

Because the blue and red maxima may occur in different sequences, this point may be unattainable. The distance-to-ideal metric identifies the discovered sequence that comes closest to this theoretical optimum:

\[
d(x,U)=\sqrt{(\tilde{B}_{max}-\tilde{B}(x))^2+(\tilde{R}_{max}-\tilde{R}(x))^2}
\]

The benchmark should report the minimum distance achieved by each method at every budget checkpoint. Lower values indicate that the method is finding better compromise variants.

## 7. Baseline Methods

AlphaVariant should be compared against baselines that represent both simple sampling strategies and established optimization strategies. This will help demonstrate whether AlphaVariant’s gains come from meaningful sequence modeling rather than from favorable benchmark construction.

| Baseline | Purpose | Expected Insight |
|---|---|---|
| Random sampling | Minimal baseline | Establishes how difficult the landscape is under unguided search. |
| Diversity sampling | Exploration baseline | Tests whether sequence-space coverage alone recovers the frontier. |
| Single-objective blue optimizer | Objective-specialized baseline | Shows whether optimizing only blue fails to recover red performance. |
| Single-objective red optimizer | Objective-specialized baseline | Shows whether optimizing only red fails to recover blue performance. |
| Scalarized Bayesian optimization | Strong scalar baseline | Tests whether fixed weighted sums or products can match AlphaVariant. |
| Multi-objective Bayesian optimization | Strong multi-objective baseline | Provides a direct comparison to standard Pareto-aware search. |
| Evolutionary algorithm / NSGA-II | Population-based baseline | Tests whether AlphaVariant improves over classical Pareto search. |

If resources are limited, the minimum recommended baseline set is **random sampling**, **single-objective blue**, **single-objective red**, and **multi-objective Bayesian optimization**. This reduced set still distinguishes general search difficulty, objective imbalance, and genuine multi-objective performance.

## 8. Reporting Structure

The final benchmark report should separate algorithmic search results from final candidate quality. This structure will make the conclusions clearer and reduce ambiguity about what AlphaVariant is optimizing.

| Figure/Table | Content | Purpose |
|---|---|---|
| Figure 1 | Blue vs. red scatter plot of full dataset with true Pareto frontier highlighted | Shows the trade-off landscape and the 10 global Pareto variants. |
| Figure 2 | Hypervolume vs. query budget | Main search-efficiency comparison. |
| Figure 3 | Pareto coverage vs. query budget | Shows recovery of globally optimal trade-off variants. |
| Figure 4 | Best product score and max-min score vs. budget | Shows ability to find balanced dual-fluorescent hits. |
| Figure 5 | Discovered candidates plotted in objective space | Visualizes where AlphaVariant searches relative to baselines. |
| Table 1 | Final metric summary at fixed budgets | Provides compact quantitative comparison. |
| Table 2 | Top AlphaVariant candidates | Lists sequence, blue, red, product score, max-min score, and Pareto status. |

The report should explicitly state that **hypervolume is the primary metric for multi-objective search**, while **product score is the primary metric for selecting final dual-fluorescent candidates**. This distinction will make the benchmark both methodologically rigorous and practically useful.

## 9. Recommended Success Criteria

AlphaVariant should be considered successful on `eqFP611_joint` if it meets several complementary criteria rather than only one. A strong result would show that AlphaVariant achieves higher hypervolume earlier than baselines, recovers a larger fraction of the 10 true Pareto-optimal sequences, and returns candidates with superior product and max-min scores.

| Criterion | Strong Evidence of Success |
|---|---|
| Search efficiency | AlphaVariant reaches the same hypervolume as baselines using fewer queries. |
| Frontier recovery | AlphaVariant recovers more of the 10 true Pareto-optimal sequences at the same budget. |
| Balanced candidate quality | AlphaVariant discovers top-ranked variants by product score and max-min score. |
| Robustness | AlphaVariant outperforms baselines consistently across random seeds. |
| Biological usefulness | Final candidates exceed dual thresholds such as wild-type or percentile-based cutoffs. |

A concise headline result could be phrased as follows:

> “On the negatively correlated `eqFP611_joint` fluorescence landscape, AlphaVariant more efficiently expanded the blue–red Pareto frontier than baseline methods, achieving higher hypervolume at fixed query budgets while recovering a larger fraction of the 10 known globally Pareto-optimal variants. AlphaVariant also produced final candidates with higher product and max-min scores, indicating improved discovery of balanced dual-fluorescent proteins.”

## 10. Suggested Analysis Workflow

The practical workflow should proceed as follows. First, compute the full-dataset blue/red normalization constants, the true Pareto frontier, the reference point, and the ideal point. Second, run AlphaVariant and each baseline under identical initializations, query budgets, and random seeds. Third, after each batch, update the discovered set and compute hypervolume, Pareto coverage, best product score, best max-min score, hit count, and minimum distance to the ideal point. Finally, aggregate results across seeds and report both curves and final-budget tables.

| Stage | Output |
|---|---|
| Dataset audit | Normalized objectives, true Pareto set, reference point, ideal point. |
| Optimization runs | Per-method, per-seed queried sequence trajectories. |
| Metric computation | Hypervolume, Pareto coverage, product score, max-min score, hit rate, distance to ideal. |
| Statistical aggregation | Mean, standard error, confidence intervals, and pairwise comparisons if needed. |
| Candidate review | Ranked AlphaVariant sequence list for downstream validation. |

## 11. Final Recommendation

Use **hypervolume** as the main benchmark metric because it evaluates whether AlphaVariant is discovering the multi-objective frontier efficiently. Use **Pareto coverage fraction** as the most interpretable global-discovery metric because the dataset reportedly has 10 true globally Pareto-optimal sequences. Use **geometric mean/product score** as the main final-candidate metric because it identifies variants that are simultaneously strong in both blue and red fluorescence. Report **max-min score**, **dual-threshold hit rate**, and **distance to the ideal point** as complementary analyses to show that the final candidates are balanced, useful, and close to the best possible compromise.

This plan will let you present AlphaVariant as a method that is not merely optimizing one fluorescence channel, but is genuinely capable of navigating a biologically meaningful trade-off landscape.

## References

[1]: /home/ubuntu/upload/pasted_content.txt "User-provided eqFP611_joint metric notes"
